Viewing Study NCT06660394

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:27 AM
Ignite Modification Date: 2026-03-29 @ 4:46 AM
Study NCT ID: NCT06660394
Status: RECRUITING
Last Update Posted: 2025-12-23
First Post: 2024-10-24
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
Sponsor: Longboard Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Dravet Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Antiseizure medication View
None Epilepsy View
None Neurodevelopmental disorders View
None Developmental and epileptic encephalopathy View
None LP352 View
None Seizures View
None DEEp SEA View
None Bexicaserin View